Abstract
Hereditary non-polyposis colorectal cancer (HNPCC) or Lynch syndrome underlies between 2 and 5% of all colorectal cancer. It is inherited as an autosomal dominant condition due to mutations in the mismatch repair genes. Fifty-four non-related index cases, 21 of them fulfilling Amsterdam criteria I or II, were studied. Ten (10/21 = 47.6%) different pathological mutations were found in this group, two of which had not previously been reported—one in MLH1 and the other in MSH2-. In the remaining patients, we also found another family with one of these new mutations, and four additional changes, two of which were also new—a pathological change in MSH2 and a second change of uncertain significance in MLH1-, while the other two changes had already been reported. Of all mutations, eight were found in MSH2 (8/15 = 53.3%) and seven in MLH1 (7/15 = 46.6%), suggesting a slightly greater involvement of MSH2 in HNPCC than MLH1 in our population, in contrast to the results reported by other authors.
Similar content being viewed by others
Abbreviations
- MMR:
-
Mismatch repair
- HNPCC:
-
Hereditary non-polyposis colorectal cancer
- CRFC:
-
Colorectal cancer
- InSIGHT database:
-
International society for gastrointestinal hereditary tumours
- CSGE:
-
Conformational-sensitive gel electrophoresis
- MLPA:
-
Multiple ligation probe amplification
References
Piñol V, Andreu M, Castells A et al (2004) Frequency of hereditary nonpolyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study. Eur J Gastroenterol Hepatol 16(1):39–45
Toribara NW, Sleisenger MH (1995) Screening for colorectal cancer. N Engl J Med 332:861–867
Pistorius S, Gorgens H, Plaschke J et al (2007) Genomic rerrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Cancer Lett 248(1):89–95
Peltomäki P (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10:735–740
Eng C, Brody LC, Wagner TM et al (2001) Steering committee of the breast cancer information core (BIC) consortium. Interpretation of molecular epidemiologic research: blinded comparison of methods for detecting germline BRCA1 mutation. J Med Genet 38:824–833
International Society for Gastrointestinal Hereditary Tumours (InSight), www.insight-group.org
Lastella P, Surdo NC, Resta N, et al. (2006) In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects. BMC Genomics 7:243
Goecke T, Schulmann K, Engel C et al (2008) Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with lynch syndrome: a report by the German HNPCC consortium. J Clin Oncol 24(26):4285–4292
Goldberg Y, Porat RM, Kedar I et al (2008) Mutation spectrum in HNPCC in the Israeli population. Fam Cancer 7(4):309–317
Nytröm-Lahti N, Wu Y, Hoisio AL et al (1996) DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 5(6):763–769
Wu Y, Nytröm-Lahti N, Osinga J et al (1997) MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosom Cancer 18:269–278
Barnetson RA, Cartwright N, van Vliet A et al (2008) Classification of ambiguous mutations in DNA mismatch repair genes identifies in a population-based study of colorectal cancer. Hum Mutat 29(3):367–374
Martinez-Bouzas C, Ojembarrena E, Beristain E et al (2007) High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country. Cancer Lett 255:295–299
Mangold E, Pagenstecher C, Friedl W et al (2005) Propping and the German HNPCC consortium, spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1721 German families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer 116:692–702
Perera S, Bapat B (2008) The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stability while p.Leu749Gln affects heterodimer formation. Hum Mutat 29(2):332
Ollila S, Sarantaus L, Kariola R et al (2006) Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein. Gastroenterology 131:1408–1417
Devlin LA, Graham CA, Price JH, Morrison PJ (2008) Germline MSH6 mutations are more prevalent in endometrial cancer patient cohorts than hereditary non polyposis colorectal cancer cohorts. Ulst Med J 77(1):25–30
Martinez-Bouzas C, Beristain E, Errasti J et al (2007) Nueva mutación en MLH1: c.306+5G>A produce un nuevo sitio de splice en una familia con cáncer de colon no poliposico. Paper presented at the XXIV Congreso Nacional de Genética Humana. Alicante 19–21 Septiembre 2007
Pineda M, Blanco I, Llort G et al (2007) Identificación de dos mutaciones recurrentes en MLH1 en nuestra población. Paper presented at the XXIV Congreso Nacional de Genética Humana. Alicante 19–21 Septiembre 2007
Ewald J, Rodrigue CM, Mourra N et al (2007) Immunohistochemical staining for mismatch repair proteins, and its relevance in the diagnosis of hereditary non-polyposis colorectal cancer. Br J Surg 94(8):1020–1027
Belvederesi L, Bianchi F, Loretelli C et al (2006) Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features. Eur J Hum Genet 14:853–859
Blasi MF, Ventura I, Aquilina G et al (2006) A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene. Cancer Res 66(18):9036–9044
Wagner A, Barrows A, Wijnen JT et al (2003) Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 72:1088–1100
Taylor CF, Charton RS, Burn J, Sheridan E, Taylor GR (2003) Genomic delections in MSH2 or MLH1 are a frequent cause of hereditary nonpolyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat 22:428–433
Gile JJ, Hogervost FB, Pals G et al (2002) Genomic delections of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 87:892–897
Picelli S, Vandrovcova J, Jones S et al (2008) Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q. BMC Cancer 8:87
Bläker H, Mechtersheimer G, Sutter C et al (2008) Recurrent deletions at 6q in early age of onset non-HNPCC and non-FAD associated intestinal carcinomas. Evidence for novel cancer susceptibility locus at 6q14–q22. Genes Chromosom Cancer 47:159–164
Acknowledgments
This work was supported by grants: (a) 200411060 from the Department of Health of the Basque Government and (b) BI0O7/CA/006 from Basque Foundation for Health Innovation and Research.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Martínez-Bouzas, C., Beristain, E., Ojembarrena, E. et al. A study on MSH2 and MLH1 mutations in hereditary nonpolyposis colorectal cancer families from the Basque Country, describing four new germline mutations. Familial Cancer 8, 533–539 (2009). https://doi.org/10.1007/s10689-009-9283-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-009-9283-3